Carregant...
The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro()
OBJECTIVE: To examine the ability of dual mTORc1/c2 inhibitors in conjunction with lapatinib to function in a synergistic manner to inhibit cell proliferation and anchorage-independent growth in bladder cancer cell lines. MATERIALS AND METHODS: We examined patient tumor samples for overexpression of...
Guardat en:
| Publicat a: | Urol Oncol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4559860/ https://ncbi.nlm.nih.gov/pubmed/24054871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2013.06.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|